CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) traded down 1.8% during trading on Friday . The stock traded as low as $100.79 and last traded at $100.79. 807 shares were traded during mid-day trading, a decline of 68% from the average session volume of 2,542 shares. The stock had previously closed at $102.67.
Analysts Set New Price Targets
Separately, UBS Group upgraded CochLear from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, June 18th.
Get Our Latest Analysis on CochLear
CochLear Stock Up 0.5%
The firm has a 50 day simple moving average of $95.83 and a 200 day simple moving average of $90.08.
About CochLear
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access